Taleen Hanania
Affiliations: | PsychoGenics Inc, Tarrytown, NY, United States |
Area:
CNS disordersGoogle:
"Taleen Hanania"Mean distance: 19.53 (cluster 32) | S | N | B | C | P |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Kabitzke P, Morales D, He D, et al. (2020) Mouse Model Systems of Autism Spectrum Disorder: Replicability and Informatics Signature. Genes, Brain, and Behavior. e12676 |
| Kaufmann WE, Sprouse J, Rebowe N, et al. (2019) ANAVEX®2-73 (blarcamesine), a Sigma-1 receptor agonist, ameliorates neurologic impairments in a mouse model of Rett syndrome. Pharmacology, Biochemistry, and Behavior. 187: 172796 |
| Dedic N, Jones PG, Hopkins SC, et al. (2019) SEP-363856, A NOVEL PSYCHOTROPIC AGENT WITH A UNIQUE, NON-D2 RECEPTOR MECHANISM OF ACTION. The Journal of Pharmacology and Experimental Therapeutics |
| Kabitzke P, Brunner D, He D, et al. (2017) Comprehensive Analysis of Two Shank3 and the Cacna1c Mouse Models of Autism Spectrum Disorder. Genes, Brain, and Behavior |
| Shao L, Campbell UC, Fang QK, et al. (2016) In vivo phenotypic drug discovery: Applying a behavioral assay to the discovery and optimization of novel antipsychotic agents Medchemcomm. 7: 1093-1101 |
| Brunner D, Kabitzke P, He D, et al. (2015) Comprehensive Analysis of the 16p11.2 Deletion and Null Cntnap2 Mouse Models of Autism Spectrum Disorder. Plos One. 10: e0134572 |
| Henry MA, Fairchild DD, Patil MJ, et al. (2015) Effect of a Novel, Orally Active Matrix Metalloproteinase-2 and -9 Inhibitor in Spinal and Trigeminal Rat Models of Neuropathic Pain. Journal of Oral & Facial Pain and Headache. 29: 286-96 |
| Chang Q, Hanania T, Mash DC, et al. (2015) Noribogaine reduces nicotine self-administration in rats. Journal of Psychopharmacology (Oxford, England). 29: 704-11 |
| Alexandrov V, Brunner D, Hanania T, et al. (2015) Reprint of: Highthroughtput analysis of behavior for drug discovery. European Journal of Pharmacology. 753: 127-34 |
| Alexandrov V, Brunner D, Hanania T, et al. (2015) High-throughput analysis of behavior for drug discovery. European Journal of Pharmacology. 750: 82-9 |